Form 4 for BNGO Bionano Genomics, Inc.
Accepted 2022-05-16 00:00:00 ET · period of report 2022-05-12 · accession 0001209191-22-029458 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-16 | 2022-05-12 | BNGO | OLDAKOWSKI MARK | COO | F - Tax | $1.41 | -41.5K | 216.7K | -16% | -$58.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-12 | F | D | 41,496 | $1.41 | 216,669 | D | — | — | (F2) Includes 3,139 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "ESPP") on June 10, 2021 and 2,940 shares acquired under the ESPP on December 10, 2021. |